Stereotactic ablative radiation (SBRT) for early stage lung cancer is a standard treatment. Join Dr. Shahed Badiyan and Dr. David Palma as they discuss four scenarios that are particularly challenging for the delivery of SBRT for lung cancer: reirradiation, a patient with interstitial lung disease, ultracentral tumor location, and oligometastatic lung cancer. We will present representative cases and discuss how we would treat patients in these challenging situations and the published data supporting our decisions.

This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.

Upon completion of this activity, the participants should be able to: 

• Understand the literature describing patient outcomes after SBRT for oligometastatic disease and lung SBRT reirradiation for NSCLC.
• Understand the literature, and when not to recommend lung SBRT for patients with interstitial lung disease.
• Understand the literature and how best to prescribe SBRT for patients with ultracentral early stage lung cancers.

• Corinne Faivre-Finn, FRCR MD PhD
• David Palma, MD, PhD, FRCPC
• Shahed Badiyan, MD

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.